Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
These dynamics can rattle even the most seasoned professionals, which is why we started StockStory – to help you separate the good companies from the bad. Keeping that in mind, here is one mid-cap stock with huge upside potential and two that could be down big.
Market Cap: $10.29 billion
Operating under the Gap, Old Navy, Banana Republic, and Athleta brands, Gap (NYSE:GAP) is an apparel and accessories retailer selling casual clothing to men, women, and children.
Why Is GAP Not Exciting?
-
Products have few die-hard fans as sales have declined by 1.3% annually over the last three years
-
Free cash flow margin dropped by 2.2 percentage points over the last year, implying the company became more capital intensive as competition picked up
-
Low returns on capital reflect management’s struggle to allocate funds effectively
At $27.40 per share, Gap trades at 12.2x forward P/E. If you’re considering GAP for your portfolio, see our FREE research report to learn more.
Market Cap: $10.18 billion
With a history dating back to 1931 and products used in over 100 countries, Baxter International (NYSE:BAX) provides essential healthcare products including dialysis therapies, IV solutions, infusion systems, surgical products, and patient monitoring technologies to hospitals and clinics worldwide.
Why Do We Avoid BAX?
-
Underwhelming constant currency revenue performance over the past two years suggests its product offering at current prices doesn’t resonate with customers
-
Earnings per share fell by 6% annually over the last five years while its revenue was flat, showing each sale was less profitable
-
Push for growth has led to negative returns on capital, signaling value destruction, and its falling returns suggest its earlier profit pools are drying up
Baxter’s stock price of $19.83 implies a valuation ratio of 9.8x forward P/E. Check out our free in-depth research report to learn more about why BAX doesn’t pass our bar.
Market Cap: $12.3 billion
Founded in 1999 and named after a naval term for a flag-bearing ship, The Ensign Group (NASDAQ:ENSG) operates skilled nursing facilities, senior living communities, and rehabilitation services across 15 states, primarily serving high-acuity patients recovering from various medical conditions.
